Sana Biotechnology Inc【SANA】株式ニュース | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Sana Biotechnology Inc (SANA)
Sana Biotechnology Inc (SANA) ニュース

Sana Biotechnology Inc (SANA)

2.42

-0.17

(-6.56%)

終了 11月16日 6:00AM

2.42

0.00

( 0.00% )

プレマーケット: 6:00PM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates

Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell...

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025

Prioritize clinical and preclinical development on type 1 diabetes (UP421 and SC451), B-cell mediated...

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors PR Newswire CAMBRIDGE, Mass...

Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference

SEATTLE, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Form 8-K - Current report

Sana Biotechnology to Present at September 2024 Investor Conferences

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates

Continue to advance hypoimmune technology in four trials across seven indications in oncology, B-cell mediated...

Monksdream

Monksdream 4週前

Monksdream

Monksdream 2月前

Monksdream

Monksdream 4月前

Monksdream

Monksdream 4月前

Monksdream

Monksdream 9月前

SANA new 52 week high

Monksdream

Monksdream 10月前

SANA up from a low in November

Moneymaker77777

Moneymaker77777 2年前

https://www.globenewswire.com/news-release/2023/03/16/2629176/0/en/Sana-Biotechnology-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Business-Updates.html

Sana Biotechnology

Ainsworth Game Technology

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約